Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu-Feng Huang

Showing results (41-50 of 256) with videos related to

Pageof 26
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 25, 2009
Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia--a postmortem studyKai Kang, Xu-Feng Huang, Qing Wang, et al.
Molecular Nutrition & Food Research|April 18, 2014
The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complicationsDanielle Camer, Yinghua Yu, Alexander Szabo, et al.
Journal of Psychopharmacology (Oxford, England)|June 15, 2012
Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat modelChao Deng, Jiamei Lian, Nagesh Pai, et al.
Scientific Reports|November 6, 2020
N-acetylcysteine prevents olanzapine-induced oxidative stress in mHypoA-59 hypothalamic neuronsZehra Boz, Minmin Hu, Yinghua Yu, et al.
Brain Research Bulletin|April 19, 2005
M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disordersKaterina Zavitsanou, Andrew Katsifis, Yinghua Yu, et al.
Current Drug Discovery Technologies|April 26, 2011
Insulin decreases therapeutic efficacy in colon cancer cell line HT29 via the activation of the PI3K/Akt pathwayJiezhong Chen, Andrew Katsifis, Changhua Hu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 12, 2005
Membrane phospholipid composition, alterations in neurotransmitter systems and schizophreniaTeresa M du Bois, Chao Deng, Xu-Feng Huang
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 24, 2014
Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D₂ but not 5-HT2A/2C bindings in rat brainsJiamei Lian, Xu-Feng Huang, Nagesh Pai, et al.
Journal of Gastrointestinal Oncology|July 20, 2012
Insulin caused drug resistance to oxaliplatin in colon cancer cell line HT29Jiezhong Chen, Xu-Feng Huang, Liang Qiao, et al.
Psychoneuroendocrinology|July 4, 2014
Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathwaysJiamei Lian, Xu-Feng Huang, Nagesh Pai, et al.
Pageof 26

Showing results (41-50 of 256) with videos related to

Sort By:
Pageof 26
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 25, 2009
Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia--a postmortem studyKai Kang, Xu-Feng Huang, Qing Wang, et al.
Molecular Nutrition & Food Research|April 18, 2014
The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complicationsDanielle Camer, Yinghua Yu, Alexander Szabo, et al.
Journal of Psychopharmacology (Oxford, England)|June 15, 2012
Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat modelChao Deng, Jiamei Lian, Nagesh Pai, et al.
Scientific Reports|November 6, 2020
N-acetylcysteine prevents olanzapine-induced oxidative stress in mHypoA-59 hypothalamic neuronsZehra Boz, Minmin Hu, Yinghua Yu, et al.
Brain Research Bulletin|April 19, 2005
M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disordersKaterina Zavitsanou, Andrew Katsifis, Yinghua Yu, et al.
Current Drug Discovery Technologies|April 26, 2011
Insulin decreases therapeutic efficacy in colon cancer cell line HT29 via the activation of the PI3K/Akt pathwayJiezhong Chen, Andrew Katsifis, Changhua Hu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 12, 2005
Membrane phospholipid composition, alterations in neurotransmitter systems and schizophreniaTeresa M du Bois, Chao Deng, Xu-Feng Huang
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 24, 2014
Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D₂ but not 5-HT2A/2C bindings in rat brainsJiamei Lian, Xu-Feng Huang, Nagesh Pai, et al.
Journal of Gastrointestinal Oncology|July 20, 2012
Insulin caused drug resistance to oxaliplatin in colon cancer cell line HT29Jiezhong Chen, Xu-Feng Huang, Liang Qiao, et al.
Psychoneuroendocrinology|July 4, 2014
Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathwaysJiamei Lian, Xu-Feng Huang, Nagesh Pai, et al.
Pageof 26